^
Association details:
| Biomarker: | FGFR3-TACC3 fusion |
|---|---|
| Cancer: | Lung Cancer |
| Drug: | LY3076226 (Microtubule inhibitor, FGFR3-targeted antibody-drug conjugate) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions
Excerpt:
Similar to RT-112 cell line, LY3076226 significantly inhibited tumor growth in lung PDX model (LXF-2226) with FGFR3-TACC3 fusion resulting in durable complete response in 100% of mice.
DOI:
https://doi.org/10.1158/1538-7445.AM2019-4835
